Straker, Richard J., Yun Song, James Sun, Adrienne B. Shannon, Leah S. Cohen, Elnara Muradova, Hala Daou, et al. “Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era.” Ann Surg Oncol 28, no. 7 (July 2021): 3512–21. https://doi.org/10.1245/s10434-020-09384-8.
Duke Surgery faculty and residents publish more than 500 peer-reviewed research articles each year, including many publications in high impact factor journals.
Search the list of publications below by faculty name or sort by division to learn more about our research endeavors.
Farrow, Nellie E., Kristen E. Rhodin, and Georgia M. Beasley. “Nodal Recurrence as Primary Driver of Early Relapse in Patients with SLN-Positive Melanoma: What Does It Mean for Providers and Patients?” Ann Surg Oncol 28, no. 7 (July 2021): 3452–54. https://doi.org/10.1245/s10434-021-09806-1.
Rosenberger, Laura H., Liza M. Quintana, Samantha M. Thomas, Suniti N. Nimbkar, Tina J. Hieken, Kandice K. Ludwig, Lisa K. Jacobs, et al. “ASO Visual Abstract: Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.” Ann Surg Oncol, June 1, 2021. https://doi.org/10.1245/s10434-021-10159-y.
Nussbaum, Daniel P., Christel N. Rushing, Zhifei Sun, Babatunde A. Yerokun, Mathias Worni, Robert S. Saunders, Mark B. McClellan, Donna Niedzwiecki, Rachel A. Greenup, and Dan G. Blazer. “Hospital-level compliance with the commission on cancer's quality of care measures and the association with patient survival.” Cancer Med 10, no. 11 (June 2021): 3533–44. https://doi.org/10.1002/cam4.3875.
Taskindoust, Mahsa, Samantha M. Thomas, Sarah L. Sammons, Oluwadamilola M. Fayanju, Gayle DiLalla, E Shelley Hwang, and Jennifer K. Plichta. “Survival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients.” In Ann Surg Oncol, 2021. https://doi.org/10.1245/s10434-021-10227-3.
Evans, Daniel R., Alexander L. Lazarides, Mark M. Cullen, Julia D. Visgauss, Jason A. Somarelli, Dan G. Blazer, Brian E. Brigman, and William C. Eward. “Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Osteosarcoma: A National Cancer Database Study.” Ann Surg Oncol, May 20, 2021. https://doi.org/10.1245/s10434-021-10099-7.
Rosenberger, Laura H., Liza M. Quintana, Samantha M. Thomas, Suniti N. Nimbkar, Tina J. Hieken, Kandice K. Ludwig, Lisa K. Jacobs, et al. “Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.” Ann Surg Oncol, May 14, 2021. https://doi.org/10.1245/s10434-021-10118-7.
DeVito, Nicholas C., Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K. S. Salama, Georgia M. Beasley, et al. “Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.” Cell Rep 35, no. 5 (May 4, 2021): 109071. https://doi.org/10.1016/j.celrep.2021.109071.
Nash, Amanda L., Samantha M. Thomas, Jennifer K. Plichta, Oluwadamilola M. Fayanju, E Shelley Hwang, Rachel A. Greenup, and Laura H. Rosenberger. “Contralateral Axillary Nodal Metastases: Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer?” In Annals of Surgical Oncology, 28:S179–80, 2021.